We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Faster Telemetry Offered by New Defibrillators

By HospiMedica staff writers
Posted on 09 Jun 2006
New implantable devices for treating patients with potentially lethal heart arrhythmias and heart failure offer faster telemetry and other improved features.

The Epic II ICD (implantable cardioverter defibrillator) and the Epic II HF CRT-D (cardiac resynchronization therapy defibrillator) devices, made by St. More...
Jude Medical (St. Paul, MN, USA), feature faster telemetry that speeds data from the ICD to the system programmer at a rate up to five times faster than previous St. Jude devices. A vibrating patient notifier in each device issues a vibration instead of an audio alert to notify patients of critical changes in device performance. Both devices have been cleared by the U.S. Food and Drug Administration (FDA).

Other features include SenseAbility, a technology designed to allow optimizing of sensing parameters that may protect against inappropriate ICD shocks; autointrinsic conduction search (AICS), intended to promote more natural heart function and minimize ventricular pacing; and DeFT (defibrillation thresholds) response technology to help physicians manage patients who require higher levels of defibrillation.

"I was impressed with the speed of the new Epic II ICD device. Many things were noticeably faster, like the ability to download stored electrograms,” said Senthil Natarajan, M.D., of Rochester General Hospital (NY, USA). "The vibrating patient notifier, which is the industry's first non-audio alert, is especially helpful for those patients who have difficulty hearing and would typically rely on a family member to listen for an alert.”

An implantable cardioverter defibrillator is used in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation. Cardiac resynchronization therapy (CRT)--delivered by an ICD or a pacemaker--resynchronizes the beating of the heart's ventricles, which often beat out of sync in heart-failure patients..


Related Links:
St. Jude Medical

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
PACS Workstation
PaxeraView PRO
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.